Abstract
Introduction: Toxoplasmosis, caused by the parasite Toxoplasma gondii, has a worldwide distribution and can be found in approximately 30% of the population. Despite its high prevalence, the disease has a limited therapeutic arsenal, consisting of medications with limited efficacy and considerable toxic effects. In this context, the search for new anti-T. gondii drugs becomes necessary, ai…